Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Timing conversions into stablecoins can protect gains during drawdowns. This piece outlines indicators and decision points for choosing pivots.
10,225 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
A U.S. freeskier who once faced a public jab from the president miles ahead in the Olympic season posts a strong qual...
Salesforce stock faces a pivotal year as AI-enhanced CRM and cloud strategy shape the upside. Here's the latest marke...
A new Nvidia platform called Vera Rubin could redefine AI economics for data centers. This piece breaks down what Ver...
Joby Aviation is set to report Q4 2025 results after the market close tonight. Analysts will track revenue, cash burn...
Thursday brought a lift to D-Wave stock as a quarterly momentum signal emerged. This guide breaks down the catalysts ...
This fresh analysis explores intuit (intu) 2026 earnings, highlighting key growth drivers, profitability advances, an...
Redwire posted a strong revenue beat but a bigger-than-expected loss, triggering a mid-day rally in its stock. This a...
As investors await plug power (plug) 2025 Q4 results, this guide breaks down what the earnings call transcript could ...
February was brutal for some software names. This piece breaks down why monday.com stock lost february, what that sig...
NCS Multistage's Q4 2025 earnings call offers insight into margins, backlog, and growth drivers. This guide translate...
Palantir Technologies stock popped on a rally driven by legal news and AI momentum. This guide explains what happened...